We are live on
!
Find out more
BFS
Bard Financial Services Portfolio holdings
AUM
$911M
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+6.93%
1 Year Est. Return
+19.14%
3 Year Est. Return
+90.1%
5 Year Est. Return
+119.62%
10 Year Est. Return
–
AUM
$1.03B
AUM Growth
+$32.7M
(+3.3%)
Cap. Flow
-$24.5M
Cap. Flow
% of AUM
-2.37%
Top 10 Holdings %
Top 10 Hldgs %
33.26%
Holding
273
New
8
Increased
71
Reduced
79
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Morningstar Wide Moat ETF
MOAT
|
+$3.46M |
| 2 |
Global X MLP ETF
MLPA
|
+$2.7M |
| 3 |
VanEck Durable High Dividend ETF
DURA
|
+$1.83M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$1.39M |
| 5 |
Franklin International Low Volatility High Dividend Index ETF
LVHI
|
+$1.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
+$13.7M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.74M |
| 3 |
Apple
AAPL
|
+$2.85M |
| 4 |
State Street SPDR S&P Dividend ETF
SDY
|
+$2.04M |
| 5 |
SABA
Saba Capital Income & Opportunities Fund II
SABA
|
+$1.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.64% |
| 2 | Healthcare | 9.42% |
| 3 | Financials | 9.34% |
| 4 | Consumer Staples | 8.73% |
| 5 | Consumer Discretionary | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNM
251
DELISTED
FANNIE MAE
FNM
| $24K | ﹤0.01% |
11,700
| – | – |
|
|
FRE
252
DELISTED
FREDDIE MAC D/B/A VOTING
FRE
| $23K | ﹤0.01% |
11,045
| – | – |
|
253
iShares Core Moderate Allocation ETF
AOM
$1.75B
| – | – |
-6,200
| Closed | -$268K |
|
254
CSX Corp
CSX
$93.4B
| – | – |
-6,750
| Closed | -$204K |
|
255
GSK
GSK
$104B
| – | – |
-8,196
| Closed | -$377K |
|
256
Milestone Scientific
MLSS
$35.3M
| – | – |
-25,000
| Closed | -$53K |
|
257
iShares Global REIT ETF
REET
$5.09B
| – | – |
-9,500
| Closed | -$227K |
|
258
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| – | – |
-720
| Closed | -$269K |
|
259
Global X SuperDividend REIT ETF
SRET
$233M
| – | – |
-5,367
| Closed | -$143K |
|
|
ALXN
260
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-1,600
| Closed | -$250K |
|
|
BMY.RT
261
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| – | – |
-19,875
| Closed | -$13.7M |
|
|
ENCO
262
DELISTED
ENCORIUM GROUP INC COM STK (DE)
ENCO
| – | – |
-25,000
| Closed | – |
|
Similar funds
IAM
NSEDCP
MSAM
SAM
CP
EAM
HWM
BVDMP
Bard Financial Services's Q1 2021 Portfolio in Review
As of Q1 2021, Bard Financial Services held 273 positions worth $1.03B, up 3.3% from $998M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Bard Financial Services's Q1 2021 filing shows 8 new, 71 increased, 79 reduced and 11 closed positions. Its largest new stake was Adeia: 73,521 shares worth $423K. The largest sale was Bristol-Myers Squibb Company Contingent Value Rights, an estimated $13.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Bard Financial Services's largest Q1 2021 buy was Adeia: 73,521 shares worth $423K.
- Bard Financial Services added most to VanEck Morningstar Wide Moat ETF in Q1 2021, an estimated $3.46M increase.
- Bard Financial Services's biggest Q1 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $7.74M.
- Bard Financial Services fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q1 2021, selling an estimated $13.7M.
- Bard Financial Services's ten largest holdings make up 33% of its $1.03B portfolio in Q1 2021.
- Bard Financial Services opened 8 new positions and closed 11 in Q1 2021.
- Bard Financial Services's portfolio value rose 3.3% quarter-over-quarter to $1.03B.
Based on Bard Financial Services's 13F filing for Q1 2021, filed 14 May 2021.